Cullinan Therapeutics (CGEM) Return on Invested Capital (2022 - 2023)
Cullinan Therapeutics has reported Return on Invested Capital over the past 2 years, most recently at 0.36% for Q3 2023.
- Quarterly results put Return on Invested Capital at 0.36% for Q3 2023, down 53.0% from a year ago — trailing twelve months through Sep 2023 was 0.36% (down 53.0% YoY), and the annual figure for FY2022 was 0.22%, changed.
- Return on Invested Capital for Q3 2023 was 0.36% at Cullinan Therapeutics, down from 0.32% in the prior quarter.
- Over the last five years, Return on Invested Capital for CGEM hit a ceiling of 0.21% in Q2 2022 and a floor of 0.36% in Q3 2023.